Simulations Plus, Inc. (SLP)
NASDAQ: SLP · Real-Time Price · USD
17.90
-0.33 (-1.81%)
Jan 2, 2026, 10:55 AM EST - Market open
Simulations Plus Employees
As of August 31, 2025, Simulations Plus had 213 total employees, including 212 full-time and 1 part-time employees. The number of employees decreased by 34 or -13.77% compared to the previous year.
Employees
213
Change (1Y)
-34
Growth (1Y)
-13.77%
Revenue / Employee
$371,732
Profits / Employee
-$303,840
Market Cap
360.59M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 213 | -34 | -13.77% |
| Aug 31, 2024 | 247 | 50 | 25.38% |
| Aug 31, 2023 | 197 | 34 | 20.86% |
| Aug 31, 2022 | 163 | 17 | 11.64% |
| Aug 31, 2021 | 146 | 9 | 6.57% |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SLP News
- 15 days ago - Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development - Business Wire
- 16 days ago - Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date - Business Wire
- 24 days ago - Simulations Plus Positioned to Capitalize on FDA's Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions - Business Wire
- 4 weeks ago - Simulations Plus: Buying On Long-Term Silico Drug-Development - Seeking Alpha
- 4 weeks ago - Simulations Plus Stock Climbs On Earnings Strength, Biotech Market Rebound - Benzinga
- 4 weeks ago - Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Simulations Plus Reports Fourth Quarter and Fiscal 2025 Financial Results - Business Wire
- 2 months ago - SIMULATIONS PLUS INVESTIGATION: Bragar Eagel & Squire, P.C. Urges Simulations Plus Investors to Contact the Firm Regarding Their Rights - GlobeNewsWire